MARKETS
Company

"There Are 'No Discussions' Happening Between AstraZeneca And Bristol Myers Squibb Over Potential Deal, A Senior Source Close To Matter Says; 'Never Was A Deal To Be Done' Between AstraZeneca And Bristol Myers Squibb" - Reuters Exclusive

Aug 5, 2026 · 08:06 AM ET· updated 1h ago

There are “no discussions” ongoing between AstraZeneca AZN.L and Bristol Myers Squibb BMY.N over a potential deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted mega

Share
Why It Matters

People were wondering if two big medicine companies might join together, but a person close to the situation said that's not happening—there are no talks between them at all. When you hear rumors about companies merging, it's good to wait for official news from the companies themselves before getting excited.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.